VistaGen Therapeutics, Inc.VistaGen Therapeutics, Inc.VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc.

No trades
See on Supercharts

Price target

13.000.00 0.00%
The 3 analysts offering 1 year price forecasts for VTGN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to VTGN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

VTGN EPS for the last quarter is −0.22 USD despite the estimation of −0.30 USD. In the next quarter EPS is expected to reach −0.36 USD. Track more of VistaGen Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter VistaGen Therapeutics, Inc. revenue is expected to reach ‪405.70 K‬ USD. Check out VistaGen Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, VTGN price target is 13.00 USD with a max estimate of 15.00 USD and a min estimate of 12.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with VTGN news and stock market news.